4-Year study tests arthritis Drug's staying power in kids

NCT ID NCT03769168

Completed Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study followed children with juvenile psoriatic arthritis or enthesitis-related arthritis for up to four years to see how well and how safely a medication called secukinumab worked over the long term. The 55 participants had already completed a previous study and chose to continue receiving the drug via injection. Doctors could adjust the dose if needed to better control a child's symptoms.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Cincinnati Childrens Hospital

Cincinnati, Ohio, 45229, United States
Legacy Emanuel Research Hospital Portland

Portland, Oregon, 97232, United States
Novartis Investigative Site

Brussels, 1200, Belgium
Novartis Investigative Site

Ghent, 9000, Belgium
Novartis Investigative Site

Freiburg im Breisgau, 79106, Germany
Novartis Investigative Site

Hamburg, 22081, Germany
Novartis Investigative Site

Saint Augustin, 53757, Germany
Novartis Investigative Site

Genova, GE, 16147, Italy
Novartis Investigative Site

Naples, 80131, Italy
Novartis Investigative Site

Krakow, 31503, Poland
Novartis Investigative Site

Moscow, 119991, Russia
Novartis Investigative Site

Saint Petersburg, 194100, Russia
Novartis Investigative Site

Voronezh, 394036, Russia
Novartis Investigative Site

Yekaterinburg, 620149, Russia
Novartis Investigative Site

Panorama, Western Cape, 7500, South Africa
Novartis Investigative Site

Cape Town, 7925, South Africa
Novartis Investigative Site

Santiago de Compostela, Galicia, 15706, Spain
Novartis Investigative Site

Valencia, 46026, Spain
Novartis Investigative Site

Istanbul, Halkali, 34303, Turkey (Türkiye)
Novartis Investigative Site

Istanbul, TUR, 34098, Turkey (Türkiye)
Novartis Investigative Site

Ankara, 06230, Turkey (Türkiye)
Novartis Investigative Site

Istanbul, 34093, Turkey (Türkiye)
St Lukes Intermountain Research Center

Boise, Idaho, 83702, United States

Conditions

Explore the condition pages connected to this study.